Gastroenterology - June 2014 Archives

https://www.youtube.com/watch?v=dGd5cIM5U0Q&feature=youtu.be&hd=1 ROCHESTER, Minn. — Researchers at Mayo Clinic released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes. The study found that the continuation of metformin after a cirrhosis diagnosis improved survival rates among diabetes patients. Metformin is usually discontinued once cirrhosis is diagnosed because of concerns about an increased risk of adverse effects associated with this treatment in patients with liver impairment. The Mayo Clinic study was recently published in Hepatology. Cirrhosis is scarring of the liver caused by forms of liver diseases, such as chronic viral hepatitis, chronic alcohol abuse and non-alcoholic fatty liver disease. This condition is the consequence of damage done to the liver over many years. As cirrhosis progresses, more and more scar tissue forms, impeding proper liver functions.

ROCHESTER, Minn. — Mayo Clinic Children’s Center has again been ranked as the top performing children’s hospital in Minnesota, Iowa and the Dakotas on U.S. News & World Report’s 2014-2015 Best Children’s Hospitals rankings. Overall rankings for the Mayo Clinic Children’s Center significantly increased in nearly all of the pediatric specialties, including cancer (#13), cardiology and heart surgery (#13), gastroenterology and GI surgery (#17), nephrology (#25), neurology and neurosurgery (#19), pulmonology (#31) and urology (#11). “The Mayo Clinic Children’s Center brings Mayo Clinic quality to children and families not only through cutting-edge interventions such as the launch of the proton beam therapy for childhood cancer in 2015 and stem cell treatment for children with heart disease, but also through the integrated, multispecialty team approach that has served as the cornerstone of the Mayo Clinic approach to patients of all ages for more than 150 years,” says hospital director Randall Flick, M.D., M.P.H.